Skip to main content
Top

Endocrine

Issue 3/2002

Content (15 Articles)

Gingival enlargement in acromegaly

I. Çapoglu, A. B. Yilmaz, N. Ünüvar, R. Orbak, H. Aksoy, H. Yesilyurt

Effects of postmenopausal hormone replacement therapy on insulin resistance

Kenan Saglam, Zülfikar Polat, M. Ilker Yilmaz, Mustafa Gulec, Seda B. Akinci

Dexamethasone and adrenocorticotropin suppress prolactin secretion in humans

Erika Hubina, György M. Nagy, Béla E. Tóth, Gabriella Iván, Zoltán Görömbey, István Szabolcs, László Kovács, Miklós I. Góth

Angiotensin-(1–7) in normal and preeclamptic pregnancy

David C. Merrill, Michael Karoly, Kai Chen, Carlos M. Ferrario, K. Bridget Brosnihan

EtOH disrupts female mammalian puberty

Nicholas Emanuele, Jassmine Ren, Nancy LaPaglia, Jennifer Steiner, Mary Ann Emanuele

Role of corticotropin-releasing hormone in ovarian steroidogenesis

Mariko Murase, Tsuguo Uemura, Yoshihito Kondoh, Toshiya Funabashi, Fumiki Hirahara

Apoptosis is developmentally regulated in rat growth plate

Dionisios Chrysis, Ola Nilsson, E. Martin Ritzen, Lars Sävendahl

Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic cushing’s syndrome

Pablo Stiefel, José S. García-Morillo, Luis Jimenez, Encarnación Pamies, María Luisa Miranda, Joaquín Carneado, José Villar, Alfonso Leal-Cerro

Combined effect of xenoestrogens and growth factors in two estrogen-responsive cell lines

Louis J. Cossette, Isabelle Gaumond, Maria-Grazia Martinoli

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.